Akili (AKLI) News Today → The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad) Free AKLI Stock Alerts $0.42 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 29 at 6:57 PM | bizjournals.comAkili to be delisted after getting acquiredMay 29 at 12:17 PM | prnewswire.comShareholder Alert: Ademi LLP investigates whether Akili, Inc. has obtained a Fair Price for its Public ShareholdersMay 29 at 8:09 AM | businesswire.comPureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health CompanyMay 29 at 8:00 AM | businesswire.comVirtual Therapeutics, Akili Interactive Enter Into Definitive Merger Agreement to Establish Leading Digital Health CompanyMay 29 at 4:10 AM | americanbankingnews.comAkili, Inc. (NASDAQ:AKLI) Short Interest UpdateMay 15, 2024 | msn.comAkili reports Q1 results; suspends outlookMay 14, 2024 | investorplace.comAKLI Stock Earnings: Akili Beats EPS, Misses Revenue for Q1 2024May 14, 2024 | businesswire.comAkili Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 3, 2024 | bizjournals.comTherapeutic video game maker Akili lays off workers for third time in 16 monthsApril 30, 2024 | investorplace.comWhy Is Akili (AKLI) Stock Up 68% Today?April 30, 2024 | businesswire.comAkili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial ResultsApril 30, 2024 | marketbeat.comTrading was temporarily halted for "AKLI" at 07:04 AM with a stated reason of "News pending."March 11, 2024 | bizjournals.comDigital medicine maker Akili slashed executive pay in 2023March 3, 2024 | finance.yahoo.comAkili Full Year 2023 Earnings: EPS Beats Expectations, Revenues LagMarch 1, 2024 | markets.businessinsider.comAkili (AKLI) Gets a Buy from TD CowenFebruary 29, 2024 | businesswire.comAkili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateFebruary 28, 2024 | benzinga.comPreview: Akili's EarningsFebruary 28, 2024 | investing.comAkili's ADHD digital therapy seeks Japan approvalFebruary 27, 2024 | msn.comCrude Oil Gains 1%; US New Home Sales Increase In JanuaryFebruary 27, 2024 | businesswire.comPureTech Founded Entity Akili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx ® for Pediatric ADHD Patients in JapanFebruary 26, 2024 | investorplace.comWhy Is Akili (AKLI) Stock Up 110% Today?February 26, 2024 | msn.comWhy Is Prescription Digital Medicine-Focused Akili Stock Trading Over 100% On Monday?February 26, 2024 | seekingalpha.comAkili's ADHD device submitted for Japanese approval, stock rallies 130%February 26, 2024 | finance.yahoo.comAkili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in JapanFebruary 26, 2024 | businesswire.comAkili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx® for Pediatric ADHD Patients in JapanFebruary 21, 2024 | finance.yahoo.comAkili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance UpdatesFebruary 21, 2024 | businesswire.comAkili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance UpdatesJanuary 15, 2024 | finance.yahoo.comAkili, Inc. (AKLI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?January 8, 2024 | bbc.comAkli Tadjer: French writer meets students in school race rowDecember 26, 2023 | cnet.comWhat to Know About EndeavorRX, the Video Game to Treat ADHDDecember 21, 2023 | finance.yahoo.comAkili, Inc. (AKLI) Upgraded to Buy: Here's What You Should KnowDecember 21, 2023 | bizjournals.comThe Petri Dish: ADHD-treating videogame cleared for teens, CRISPR exec resignsDecember 19, 2023 | morningstar.comAkili Inc Ordinary SharesDecember 18, 2023 | finance.yahoo.comEndeavorRxⓇ, World’s First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17November 15, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Urogen Pharma (URGN) and Akili (AKLI)November 14, 2023 | morningstar.comAkili Inc Ordinary Shares AKLINovember 13, 2023 | finance.yahoo.comAkili, Inc. (NASDAQ:AKLI) Q3 2023 Earnings Call TranscriptNovember 10, 2023 | finanznachrichten.deAkili Reports Third Quarter 2023 Financial Results and Provides Business UpdateOctober 14, 2023 | tmcnet.comEmployees with ADHD Aren't Reaching Their Full Potential at Work, Akili Study FindsOctober 12, 2023 | finance.yahoo.comEmployees with ADHD Aren’t Reaching Their Full Potential at Work, Akili Study FindsOctober 6, 2023 | finance.yahoo.comAkili Announces Leadership TransitionOctober 5, 2023 | markets.businessinsider.comAnalyst Affirms Buy Rating for Akili, Emphasizing Shift to OTC Strategy and Potential Strategic PartnershipsOctober 2, 2023 | markets.businessinsider.comBuy Rating on Akili’s Stock: Strategic Shift, Cash Management, and Anticipated FDA Clearances Bolster OptimismSeptember 21, 2023 | stockhouse.comAkili Releases EndeavorOTC(TM) on Android(TM) Devices, Expanding Treatment Access for Millions of Adults with ADHDSeptember 15, 2023 | finance.yahoo.comInsider Sell: CEO Martucci Walter Edward II Sells 2,353 Shares of Akili IncSeptember 13, 2023 | finance.yahoo.comAkili Announces Business Transformation, Focusing on Non-prescription ModelSeptember 13, 2023 | markets.businessinsider.comAkili Plans To Transform To Non-prescription Model; To Cut Workforce By Approx. 40%September 13, 2023 | marketbeat.comTrading was temporarily halted for "AKLI" at 07:09 AM with a stated reason of "News pending."August 14, 2023 | insidermonkey.comAkili, Inc. (NASDAQ:AKLI) Q2 2023 Earnings Call TranscriptAugust 10, 2023 | msn.comAkili, Inc. reports Q2 results Get Akili News Delivered to You Automatically Sign up to receive the latest news and ratings for AKLI and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s arrest is phase one (Ad)In this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now. AKLI Media Mentions By Week AKLI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKLI News Sentiment▼0.230.78▲Average Medical News Sentiment AKLI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKLI Articles This Week▼71▲AKLI Articles Average Week Get Akili News Delivered to You Automatically Sign up to receive the latest news and ratings for AKLI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Getaround News Semper Paratus Acquisition News KORU Medical Systems News BlueRiver Acquisition News BrainsWay News Sensus Healthcare News Health Sciences Acquisitions Co. 2 News Allurion Technologies News Pro-Dex News enVVeno Medical News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AKLI) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akili, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
